Is ABDX or GDR more profitable?

Abingdon Health has a net margin of -33.88% compared to genedrive's net margin of -500.75%. Abingdon Health's return on equity of -55.91% beat genedrive's return on equity. Company Net Margins Return on Equity Return on Assets Abingdon Health -33.88% -55.91% -17.93% genedrive -500.75% -1,044.57% -74.09%

Which has higher valuation and earnings, AGL or ABDX?

Abingdon Health has higher revenue and earnings than ANGLE. Abingdon Health is trading at a lower price-to-earnings ratio than ANGLE, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio ANGLE £2.62M 2.89 -£21.76M -£4.80 N/A Abingdon Health £9.57M 2.79 -£796.37K -£0.81 N/A

Is AGL or ABDX more profitable?

Abingdon Health has a net margin of -33.88% compared to ANGLE's net margin of -1,444.04%. Abingdon Health's return on equity of -55.91% beat ANGLE's return on equity. Company Net Margins Return on Equity Return on Assets ANGLE -1,444.04% -191.36% -29.89% Abingdon Health -33.88% -55.91% -17.93%

Does the media prefer AGL or ABDX?

In the previous week, Abingdon Health had 1 more articles in the media than ANGLE. MarketBeat recorded 2 mentions for Abingdon Health and 1 mentions for ANGLE. ANGLE's average media sentiment score of 0.75 beat Abingdon Health's score of 0.00 indicating that ANGLE is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment ANGLE 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Abingdon Health 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Is ABDX or GENI more profitable?

Abingdon Health has a net margin of -33.88% compared to GENinCode's net margin of -202.42%. Abingdon Health's return on equity of -55.91% beat GENinCode's return on equity. Company Net Margins Return on Equity Return on Assets Abingdon Health -33.88% -55.91% -17.93% GENinCode -202.42% -481.34% -63.99%

Does the media refer more to ABDX or GENI?

In the previous week, GENinCode had 3 more articles in the media than Abingdon Health. MarketBeat recorded 5 mentions for GENinCode and 2 mentions for Abingdon Health. Abingdon Health's average media sentiment score of 0.00 beat GENinCode's score of -0.31 indicating that Abingdon Health is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Abingdon Health 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral GENinCode 0 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media refer more to PRM or ABDX?

In the previous week, Abingdon Health had 1 more articles in the media than Proteome Sciences. MarketBeat recorded 2 mentions for Abingdon Health and 1 mentions for Proteome Sciences. Abingdon Health's average media sentiment score of 0.00 beat Proteome Sciences' score of -0.71 indicating that Abingdon Health is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Proteome Sciences 0 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Negative Abingdon Health 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Abingdon Health (ABDX) Competitors

GBX 10.57 -0.43 (-3.95%)

As of 10/2/2026 12:31 PM Eastern

Compare

ABDX vs. GDR, YGEN, AGL, GENI, and PRM

Should you buy Abingdon Health stock or one of its competitors? Abingdon Health's main competitors and comparable companies include genedrive (GDR), Yourgene Health (YGEN), ANGLE (AGL), GENinCode (GENI), and Proteome Sciences (PRM). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "life sciences tools & services" industry.

How does Abingdon Health compare to genedrive?

Abingdon Health (LON:ABDX) and genedrive (LON:GDR) are both small-cap healthcare companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, earnings, media sentiment, valuation, dividends, profitability, risk and analyst recommendations.

Abingdon Health has a net margin of -33.88% compared to genedrive's net margin of -500.75%. Abingdon Health's return on equity of -55.91% beat genedrive's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Abingdon Health	-33.88%	-55.91%	-17.93%
genedrive	-500.75%	-1,044.57%	-74.09%

Abingdon Health has a beta of 0.132, suggesting that its stock price is 87% less volatile than the broader market. Comparatively, genedrive has a beta of 0.968, suggesting that its stock price is 3% less volatile than the broader market.

3.7% of Abingdon Health shares are held by institutional investors. Comparatively, 0.1% of genedrive shares are held by institutional investors. 8.0% of Abingdon Health shares are held by company insiders. Comparatively, 28.1% of genedrive shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

In the previous week, Abingdon Health had 2 more articles in the media than genedrive. MarketBeat recorded 2 mentions for Abingdon Health and 0 mentions for genedrive. Abingdon Health's average media sentiment score of 0.00 equaled genedrive'saverage media sentiment score.

Company	Overall Sentiment
Abingdon Health	Neutral
genedrive	Neutral

Abingdon Health has higher revenue and earnings than genedrive. Abingdon Health is trading at a lower price-to-earnings ratio than genedrive, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Abingdon Health	£9.57M	2.79	-£796.37K	-£0.81	N/A
genedrive	£929K	20.05	-£21.22M	-£0.79	N/A

Summary

Abingdon Health beats genedrive on 7 of the 12 factors compared between the two stocks.

How does Abingdon Health compare to Yourgene Health?

Abingdon Health (LON:ABDX) and Yourgene Health (LON:YGEN) are both small-cap healthcare companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, media sentiment, risk, earnings, dividends, institutional ownership, profitability and valuation.

Abingdon Health has a beta of 0.132, suggesting that its share price is 87% less volatile than the broader market. Comparatively, Yourgene Health has a beta of 0.86, suggesting that its share price is 14% less volatile than the broader market.

Yourgene Health has a net margin of -27.55% compared to Abingdon Health's net margin of -33.88%. Yourgene Health's return on equity of -27.06% beat Abingdon Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Abingdon Health	-33.88%	-55.91%	-17.93%
Yourgene Health	-27.55%	-27.06%	-6.71%

Abingdon Health has higher earnings, but lower revenue than Yourgene Health. Abingdon Health is trading at a lower price-to-earnings ratio than Yourgene Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Abingdon Health	£9.57M	2.79	-£796.37K	-£0.81	N/A
Yourgene Health	£29.67M	0.00	-£8.17M	-£0.01	N/A

In the previous week, Abingdon Health had 2 more articles in the media than Yourgene Health. MarketBeat recorded 2 mentions for Abingdon Health and 0 mentions for Yourgene Health. Abingdon Health's average media sentiment score of 0.00 equaled Yourgene Health'saverage media sentiment score.

Company	Overall Sentiment
Abingdon Health	Neutral
Yourgene Health	Neutral

3.7% of Abingdon Health shares are held by institutional investors. Comparatively, 23.3% of Yourgene Health shares are held by institutional investors. 8.0% of Abingdon Health shares are held by company insiders. Comparatively, 64.4% of Yourgene Health shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Summary

Yourgene Health beats Abingdon Health on 8 of the 11 factors compared between the two stocks.

How does Abingdon Health compare to ANGLE?

ANGLE (LON:AGL) and Abingdon Health (LON:ABDX) are both small-cap healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their dividends, institutional ownership, valuation, media sentiment, earnings, analyst recommendations, profitability and risk.

ANGLE has a beta of 0.22, indicating that its share price is 78% less volatile than the broader market. Comparatively, Abingdon Health has a beta of 0.132, indicating that its share price is 87% less volatile than the broader market.

Abingdon Health has higher revenue and earnings than ANGLE. Abingdon Health is trading at a lower price-to-earnings ratio than ANGLE, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
ANGLE	£2.62M	2.89	-£21.76M	-£4.80	N/A
Abingdon Health	£9.57M	2.79	-£796.37K	-£0.81	N/A

In the previous week, Abingdon Health had 1 more articles in the media than ANGLE. MarketBeat recorded 2 mentions for Abingdon Health and 1 mentions for ANGLE. ANGLE's average media sentiment score of 0.75 beat Abingdon Health's score of 0.00 indicating that ANGLE is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
ANGLE	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Abingdon Health	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

17.5% of ANGLE shares are owned by institutional investors. Comparatively, 3.7% of Abingdon Health shares are owned by institutional investors. 2.7% of ANGLE shares are owned by insiders. Comparatively, 8.0% of Abingdon Health shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Abingdon Health has a net margin of -33.88% compared to ANGLE's net margin of -1,444.04%. Abingdon Health's return on equity of -55.91% beat ANGLE's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
ANGLE	-1,444.04%	-191.36%	-29.89%
Abingdon Health	-33.88%	-55.91%	-17.93%

Summary

Abingdon Health beats ANGLE on 8 of the 13 factors compared between the two stocks.

How does Abingdon Health compare to GENinCode?

Abingdon Health (LON:ABDX) and GENinCode (LON:GENI) are both small-cap healthcare companies, but which is the better business? We will compare the two companies based on the strength of their dividends, profitability, valuation, institutional ownership, risk, earnings, media sentiment and analyst recommendations.

Abingdon Health has higher revenue and earnings than GENinCode. Abingdon Health is trading at a lower price-to-earnings ratio than GENinCode, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Abingdon Health	£9.57M	2.79	-£796.37K	-£0.81	N/A
GENinCode	£3.08M	1.79	-£6.10M	-£2.08	N/A

Abingdon Health has a beta of 0.132, meaning that its share price is 87% less volatile than the broader market. Comparatively, GENinCode has a beta of 0.59, meaning that its share price is 41% less volatile than the broader market.

Abingdon Health has a net margin of -33.88% compared to GENinCode's net margin of -202.42%. Abingdon Health's return on equity of -55.91% beat GENinCode's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Abingdon Health	-33.88%	-55.91%	-17.93%
GENinCode	-202.42%	-481.34%	-63.99%

In the previous week, GENinCode had 3 more articles in the media than Abingdon Health. MarketBeat recorded 5 mentions for GENinCode and 2 mentions for Abingdon Health. Abingdon Health's average media sentiment score of 0.00 beat GENinCode's score of -0.31 indicating that Abingdon Health is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Abingdon Health	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
GENinCode	0 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

3.7% of Abingdon Health shares are owned by institutional investors. Comparatively, 11.4% of GENinCode shares are owned by institutional investors. 8.0% of Abingdon Health shares are owned by company insiders. Comparatively, 8.4% of GENinCode shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Summary

Abingdon Health beats GENinCode on 8 of the 13 factors compared between the two stocks.

How does Abingdon Health compare to Proteome Sciences?

Proteome Sciences (LON:PRM) and Abingdon Health (LON:ABDX) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their earnings, risk, profitability, dividends, valuation, media sentiment, analyst recommendations and institutional ownership.

In the previous week, Abingdon Health had 1 more articles in the media than Proteome Sciences. MarketBeat recorded 2 mentions for Abingdon Health and 1 mentions for Proteome Sciences. Abingdon Health's average media sentiment score of 0.00 beat Proteome Sciences' score of -0.71 indicating that Abingdon Health is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Proteome Sciences	0 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Negative
Abingdon Health	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Abingdon Health has higher revenue and earnings than Proteome Sciences. Abingdon Health is trading at a lower price-to-earnings ratio than Proteome Sciences, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Proteome Sciences	£3.77M	1.40	-£4.08M	-£1.04	N/A
Abingdon Health	£9.57M	2.79	-£796.37K	-£0.81	N/A

Proteome Sciences has a beta of 0.157, indicating that its share price is 84% less volatile than the broader market. Comparatively, Abingdon Health has a beta of 0.132, indicating that its share price is 87% less volatile than the broader market.

Abingdon Health has a net margin of -33.88% compared to Proteome Sciences' net margin of -61.46%. Proteome Sciences' return on equity of 23.85% beat Abingdon Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Proteome Sciences	-61.46%	23.85%	-19.25%
Abingdon Health	-33.88%	-55.91%	-17.93%

0.0% of Proteome Sciences shares are held by institutional investors. Comparatively, 3.7% of Abingdon Health shares are held by institutional investors. 36.7% of Proteome Sciences shares are held by insiders. Comparatively, 8.0% of Abingdon Health shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Summary

Abingdon Health beats Proteome Sciences on 9 of the 13 factors compared between the two stocks.

Get Abingdon Health News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ABDX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

ABDX vs. The Competition

Export

Metric	Abingdon Health	Life Sciences Tools & Services Industry	Healthcare Sector	LON Exchange
Market Cap	£26.71M	£10.56B	£7.14B	£2.81B
Dividend Yield	N/A	1.45%	2.53%	6.18%
P/E Ratio	-13.04	74.99	274.83	366.16
Price / Sales	2.79	109.16	616.61	89,437.04
Price / Cash	2.25	26.96	77.60	27.89
Price / Book	14.52	6.85	10.93	6.83
Net Income	-£796.37K	£57.48B	£3.51B	£5.89B
7 Day Performance	0.87%	2.53%	-2.00%	-0.73%
1 Month Performance	-1.08%	8.43%	-6.15%	16.59%
1 Year Performance	74.64%	32.93%	7.45%	23.09%

Abingdon Health Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
ABDX Abingdon Health	N/A	GBX 10.57 -3.9%	N/A	+71.0%	£26.71M	£9.57M	N/A	84	Gap Up
GDR genedrive	N/A	GBX 1.20 +2.1%	N/A	+391.5%	£19.27M	£929K	N/A	43	Gap Up
YGEN Yourgene Health	N/A	N/A	N/A	N/A	£16.43M	£29.67M	N/A	253
AGL ANGLE	N/A	GBX 2.35 -11.3%	N/A	-14.5%	£7.58M	£2.62M	N/A	650	News Coverage Gap Up
GENI GENinCode	N/A	GBX 0.90 +2.7%	N/A	-81.3%	£6.77M	£3.08M	N/A	2,300	Earnings Report Gap Up

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (LON:ABDX) was last updated on 10/3/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Abingdon Health (ABDX) Competitors

ABDX vs. GDR, YGEN, AGL, GENI, and PRM

How does Abingdon Health compare to genedrive?

Summary

How does Abingdon Health compare to Yourgene Health?

Summary

How does Abingdon Health compare to ANGLE?

Summary

How does Abingdon Health compare to GENinCode?

Summary

How does Abingdon Health compare to Proteome Sciences?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ABDX vs. The Competition

Abingdon Health Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Abingdon Health (ABDX) Competitors

ABDX vs. GDR, YGEN, AGL, GENI, and PRM

How does Abingdon Health compare to genedrive?

Is ABDX or GDR more profitable?

Which has more volatility and risk, ABDX or GDR?

Do insiders & institutionals believe in ABDX or GDR?

Does the media favor ABDX or GDR?

Which has better valuation & earnings, ABDX or GDR?

Summary

How does Abingdon Health compare to Yourgene Health?

Which has more risk and volatility, ABDX or YGEN?

Is ABDX or YGEN more profitable?

Which has better earnings and valuation, ABDX or YGEN?

Does the media favor ABDX or YGEN?

Do insiders & institutionals have more ownership in ABDX or YGEN?

Summary

How does Abingdon Health compare to ANGLE?

Which has more volatility and risk, AGL or ABDX?

Which has higher valuation and earnings, AGL or ABDX?

Does the media prefer AGL or ABDX?

Do institutionals and insiders have more ownership in AGL or ABDX?

Is AGL or ABDX more profitable?

Summary

How does Abingdon Health compare to GENinCode?

Which has stronger valuation & earnings, ABDX or GENI?

Which has more risk & volatility, ABDX or GENI?

Is ABDX or GENI more profitable?

Does the media refer more to ABDX or GENI?

Do institutionals and insiders have more ownership in ABDX or GENI?

Summary

How does Abingdon Health compare to Proteome Sciences?

Does the media refer more to PRM or ABDX?

Which has better valuation & earnings, PRM or ABDX?

Which has more volatility & risk, PRM or ABDX?

Is PRM or ABDX more profitable?

Do insiders & institutionals believe in PRM or ABDX?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ABDX vs. The Competition

Abingdon Health Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools